Comments
The Covid-19 pandemic has given an opportunity for Indian Pharma industry to fortify its position, according to K Satish Reddy, Chairman, Dr Reddy’s Laboratories Ltd.
Reddy, who is also the chairman of the board of governors of National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, was speaking at the eighth convocation of the Institute held at its campus here on Friday.
There has been increasing collaboration between Indian pharma industry and global players in the form of licensing agreements to speed up availability of drugs, Reddy said.
‘Digital health here to stay’
Referring to few ‘paradigm shifts’ in Indian pharma industry in Covid-19 times, he said, “digital health is here to stay along with other including digital marketing.”
To reduce supply chain risks, localisation of raw material production is being taken with a ‘push’ from the government which has come up with new schemes to support industry in this regard.
On the opportunities for the students, Reddy said: “Given the current situation, things were uncertain for many students. However, those who can manage this uncertainty will emerge stronger.’’
NIPER placement record
In her report, Shashi Bala Singh, Director, NIPER-Hyderabad, said the students of the institute have been able to achieve 100 per cent placements for the last three years.
During Covid-19 times, the institute is continuing academic and research programs with pandemic norms in mind and also filed two patents, she said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.